Trevi Therapeutics, Inc. (TRVI)
NASDAQ·Healthcare·Biotechnology
$16.07
+1.04%
Mkt Cap $2.45B
Analyst Ratings
Buy
14
Hold
0
Sell
0
Price Target (9 analysts)
$25.00
Range $20.00 – $30.00
Implied Upside
+55.6%
Consensus $25.00 vs current $16.07
NASDAQ·Healthcare·Biotechnology
$16.07
+1.04%
Mkt Cap $2.45B
Buy
14
Hold
0
Sell
0
Price Target (9 analysts)
$25.00
Range $20.00 – $30.00
+55.6%
Consensus $25.00 vs current $16.07